Low serum 25-hydroxyvitamin D is associated with an increased risk for respiratory tract infection hospitalization.
It can cause an infection that lasts for weeks ...
RIP Neil ...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Health Canada has approved ENFLONSIA® (clesrovimab) for the prevention of respiratory syncytial virus (RSV) ...
Guillain-Barré Syndrome Presenting as Pseudo-Cerebellar Syndrome: A Case Report from a Resource-Limited Setting in Sub-Saharan Africa Guillain-Barré Syndrome (GBS) is the most frequent cause of acute ...
NTLA stock faces binary risk: success could unlock multi-billion dollar markets, while setbacks may erase hundreds of ...
Thank you, and welcome to everybody joining us today. Alongside this, we're continuing to make excellent progress in R&D, strengthening our late-stage portfolio and already securing four FDA approvals ...
The rates of new diagnoses for COPD and asthma between March 2020 and November 2024 in England were less than what was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results